Clovis Oncology (CLVS) Announces First Quarter 2013 Operating Results  
5/7/2013 8:10:52 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for its first quarter ended March 31, 2013, and provided an update for its clinical development programs. This update describes, for the first time, the Company’s progress in developing a new formulation for CO-1686, including results from a recently initiated pharmacokinetic (PK) study in healthy human volunteers.

Help employers find you! Check out all the jobs and post your resume.